Susquehanna International Group’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 6908 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6847 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6588 |
|
|
2024
Q3 | – | Sell |
-16,964
| Closed | -$746K | – | 6186 |
|
|
2024
Q2 | $746K | Sell |
16,964
-55,397
| -77% | -$2.44M | ﹤0.01% | 2936 |
|
|
2024
Q1 | $3.63M | Sell |
72,361
-141,755
| -66% | -$7.12M | ﹤0.01% | 1251 |
|
|
2023
Q4 | $12.9M | Buy |
214,116
+196,964
| +1,148% | +$11.9M | ﹤0.01% | 575 |
|
|
2023
Q3 | $978K | Buy |
+17,152
| New | +$978K | ﹤0.01% | 2588 |
|